Weitz Investment Management’s Core Laboratories CLB Stock Holding History

Weitz Investment Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,000	Closed	-$1.09M	–	66
2015 Q4	$1.09M	Sell	10,000 -219,200	-96%	-$25.1M	0.04%	61
2015 Q3	$22.9M	Sell	229,200 -76,000	-25%	-$8.27M	0.71%	44
2015 Q2	$34.8M	Sell	305,200 -24,000	-7%	-$2.91M	0.98%	36
2015 Q1	$34.4M	Buy	329,200 +180,700	+122%	+$19.3M	0.93%	39
2014 Q4	$17.9M	Buy	+148,500	New	+$19.5M	0.5%	47

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Weitz Investment Management's CLB Position: Q1 2016 in Review

Weitz Investment Management sold out of Core Laboratories (CLB) in Q1 2016, closing a stake of 10,000 shares — an estimated $1.09M sold.

Weitz Investment Management first reported a position in CLB in Q4 2014 and held it in 5 quarters. The position peaked at $34.8M in Q2 2015. 365 funds tracked by Wall St. Rank hold CLB as of Q1 2016.

Weitz Investment Management reported no remaining Core Laboratories position as of Q1 2016 after selling out during the quarter.
Weitz Investment Management sold 10,000 Core Laboratories shares in Q1 2016, an estimated $1.09M.
Weitz Investment Management first reported a position in Core Laboratories in Q4 2014 and held it in 5 quarters.
Weitz Investment Management's Core Laboratories position peaked at $34.8M in Q2 2015.
365 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2016.

Based on Weitz Investment Management's 13F filing for Q1 2016, filed 13 May 2016.